NASDAQ: PTCT - PTC Therapeutics, Inc.

Lønnsomhet i seks måneder: +28.52%
Sektor: Healthcare

Kampanjeplan PTC Therapeutics, Inc.

Avansert tidsplan Enkel graf
Financial Markets by TradingView

Om selskapet

PTC Therapeutics, Inc., биофармацевтическая компания, занимается открытием, разработкой и коммерциализацией лекарств для лечения редких заболеваний. Компания предлагает Трансларна (аталурен) и Эмфлаза (дефлазакорт) для лечения нонсенс-мутации мышечной дистрофии Дюшенна у амбулаторных пациентов.

flere detaljer
Компания занимается разработкой Translarna, которая находится в фазе 2 клинических исследований для лечения нонсенс-мутации аниридии и синдрома нонсенс-мутации Драве CDKL5; и RG7916 и RO7034067 для лечения пациентов со спинальной мышечной атрофией, а также PTC596 и PTC299, низкомолекулярный ингибитор дигидроорататдегидрогеназы (DHODH), который ингибирует синтез пиримидиновых нуклеотидов de novo, который находится в фазе 1 стадии клинической разработки для лечения больных раком. . Компания также разрабатывает кандидатный продукт для генной терапии, который включает PTC-AADC для лечения дефицита декарбоксилазы ароматических L-аминокислот. Он сотрудничает с F. Hoffman-La Roche Ltd и Hoffman-La Roche Inc., а также с Фондом спинальной мышечной атрофии с целью разработки и коммерциализации соединений, выявленных в рамках спонсируемой им программы исследований по спинальной мышечной атрофии; научно-исследовательское сотрудничество с Массачусетской больницей общего профиля для лечения редких генетических заболеваний, вызванных пре-мРНК; и Akcea Therapeutics, Inc. для коммерциализации Тегседи и Вайливра для лечения редких заболеваний в Латинской Америке и Карибском бассейне. Компания PTC Therapeutics, Inc. была основана в 1998 году, ее штаб-квартира находится в Саут-Плейнфилде, штат Нью-Джерси.
Legg til i sammenligningslisten
Legg til overvåkningsliste
Legg til portefølje
Legg til prisvarsel

IPO date 2013-06-20
ISIN US69366J2006
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.ptcbio.com
Цена ао 43.94
Prisendring per dag: 0% (43.94)
Prisendring per uke: -4.02% (45.78)
Prisendring per måned: -7.22% (47.36)
Prisendring over 3 måneder: +12.26% (39.14)
Prisendring over seks måneder: +28.52% (34.19)
Prisendring per år: +60.78% (27.33)
Prisendring over 3 år: +8.41% (40.53)
Prisendring over 5 år: -14.68% (51.5)
Prisendring over 10 år: 0% (43.94)
Prisendring siden begynnelsen av året: -3.11% (45.35)
Alle parametere

Undervurdering

Navn Betydning Karakter
P/S 2.2 7
P/BV -2.52 0
P/E 0 0
EV/EBITDA -16.73 0
Total: 4.25

Effektivitet

Navn Betydning Karakter
ROA, % -32.92 0
ROE, % 76.55 10
Total: 3.33

Utbytte

Navn Betydning Karakter
Div yield, % 0 0
DSI 0 0
Total: 0

Plikt

Navn Betydning Karakter
Debt/EBITDA -17.02 10
Total: 7

Vekstimpuls

Navn Betydning Karakter
Lønnsomhet Revenue, % 205.48 10
Lønnsomhet Ebitda, % 182.83 10
Lønnsomhet EPS, % 96.08 9
Total: 9.6
Flere detaljer

Transaksjonsdato Avsløringsdato Insider Type Pris Volum Mengde Del opp til, % Del etterpå, % Dokument
31.12.2024 31.12.2024 Klein Matthew B.
Director		 Kjøpe 45.16 373 880 8279 0 0.01 link
19.04.2024 22.04.2024 Klein Matthew B.
CHIEF EXECUTIVE OFFICER		 Salg 24.89 83 655 3361 0 0 link
17.04.2024 19.04.2024 Klein Matthew B.
CHIEF EXECUTIVE OFFICER		 Salg 25.14 32 858 1307 0 0 link
17.04.2024 19.04.2024 Pauwels Eric
CHIEF EXECUTIVE OFFICER		 Salg 25.14 19 785 787 0 0 link
06.09.2023 08.09.2023 Young Alethia
Director		 Salg 39.86 465 007 11666 0 -0.02 link
06.09.2023 08.09.2023 Young Alethia
Director		 Kjøpe 27.85 324 898 11666 0 0.02 link
09.01.2023 11.01.2023 Utter Christine Marie
SVP, FINANCE & CAO		 Salg 41.66 29 412 706 0 0 link
09.01.2023 11.01.2023 Peltz Stuart Walter
CHIEF EXECUTIVE OFFICER		 Salg 41.66 11 623 279 0 0 link
09.01.2023 11.01.2023 Peltz Stuart Walter
CHIEF EXECUTIVE OFFICER		 Salg 41.66 74 405 1786 0 0 link
09.01.2023 11.01.2023 Pauwels Eric
CHIEF BUSINESS OFFICER		 Salg 41.66 35 744 858 0 0 link
09.01.2023 11.01.2023 Klein Matthew B.
CHIEF OPERATING OFFICER		 Salg 41.66 30 453 731 0 0 link
09.01.2023 11.01.2023 Boulding Mark Elliott
EXEC. VP AND CLO		 Salg 41.66 34 786 835 0 0 link
09.01.2023 11.01.2023 Hill Emily Luisa
CHIEF FINANCIAL OFFICER		 Salg 41.66 31 578 758 0 0 link
09.01.2023 11.01.2023 Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER		 Salg 41.66 1 791 43 0 0 link
09.01.2023 11.01.2023 Almstead Neil Gregory
CHIEF TECHNICAL OPS OFFICER		 Salg 41.66 29 829 716 0 0 link
13.04.2022 15.04.2022 Boulding Mark Elliott
EXEC. VP AND CLO		 Salg 45.17 102 807 2276 0 0 link
25.01.2022 27.01.2022 Almstead Neil Gregory
Chief Technical Ops Officer		 Salg 39.31 1 690 43 0 0 link
25.01.2022 27.01.2022 Hill Emily Luisa
Chief Financial Officer		 Salg 39.31 8 294 211 0 0 link
25.01.2022 27.01.2022 Pauwels Eric
Chief Business Officer		 Salg 39.31 14 112 359 0 0 link
25.01.2022 27.01.2022 Peltz Stuart Walter
Chief Executive Officer		 Salg 39.31 12 972 330 0 0 link
01.02.2021 02.02.2021 Svoronos Dawn
Director		 Salg 56.96 28 822 506 0 0 link
01.02.2021 02.02.2021 Peltz Stuart Walter
Chief Executive Officer		 Salg 56.96 16 120 283 0 0 link
01.02.2021 02.02.2021 Peltz Stuart Walter
Chief Executive Officer		 Salg 56.96 112 097 1968 0 0 link
01.02.2021 02.02.2021 Pauwels Eric
Chief Business Officer		 Salg 56.96 20 620 362 0 0 link
01.02.2021 02.02.2021 Almstead Neil Gregory
Chief Technical Ops Officer		 Salg 56.96 1 595 28 0 0 link

Institusjoner Volum Dele, %
Wellington Management Group, LLP 9816603 12.81
Vanguard Group Inc 8800843 11.49
Blackrock Inc. 7634122 9.97
RTW Investments LP 7423970 9.69
Armistice Capital, LLC 6864000 8.96
State Street Corporation 4633955 6.05
Camber Capital Management LP 4000000 5.22
COWEN AND COMPANY, LLC 3725626 4.86
Janus Henderson Group PLC 2612593 3.41
FMR, LLC 1814421 2.37

ETF Dele, % Lønnsomhet for året, % Utbytte, %
Direxion mRNA ETF 4.89 0
iShares Neuroscience and Healthcare ETF 4.39568 19.72 0.03
Motley Fool Small-Cap Growth ETF 3.69 33.83 5.41
Global X Guru Index ETF 1.62261 38.91 0.71623
Virtus LifeSci Biotech Products ETF 1.41975 36.79 0.13953
Invesco Dorsey Wright Healthcare Momentum ETF 1.07011 1.46 0.12263
First Trust Small Cap Growth AlphaDEX Fund 0.54286 42.5 1.22182
ProShares UltraShort Nasdaq Biotechnology 0.4 -40.36 1.76
Direxion Daily S&P Biotech Bull 3x Shares 0.30035 4067.92 0.25924
Future Tech ETF 0.27263 426.34 0.8416
Principal Healthcare Innovators ETF 0.27263 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.26702 28.58 0.8565
Inspire Small/Mid Cap ETF 0.2159 28.65 1.92038
First Trust Small Cap Core AlphaDEX Fund 0.20263 12.85 1.87983
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.18137 24.75 1.59225
ProShares Ultra Nasdaq Biotechnology 0.18076 51.7 0.85651
iShares Russell 2000 Growth ETF 0.15722 38.04 0.6026
Vanguard Russell 2000 Growth ETF 0.15 17.39 0.60264
BNY Mellon US Small Cap Core Equity ETF 0.13359 30.07 1.75333
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.12259 31.36 1.41955
First Trust Multi Cap Growth AlphaDEX Fund 0.11224 41.56 1.02425
Vanguard Russell 2000 ETF 0.1 14.37 1.48801
iShares Morningstar Small-Cap Growth ETF 0.08016 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.08016 590.83 0.72598
Schwab U.S. Small-Cap ETF 0.06928 13.35 1.51433
iShares Morningstar Small-Cap ETF 0.06073 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.06073 391.25 1.60498
ProShares UltraPro Russell2000 0.06028 89.82 1.47873
iShares ESG Aware MSCI USA Small-Cap ETF 0.05099 12.78 1.49366
Invesco Russell 2000 Dynamic Multifactor ETF 0.04903 6.38 1.64004
iShares Morningstar Small Cap Value ETF 0.04061 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.04061 199.14 2.50476
SPDR SSGA US Small Cap Low Volatility Index ETF 0.0396 34.33 2.97092
Fidelity MSCI Health Care Index ETF 0.03507 0.1657 1.46057
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.01848 15.15 1.75869
Humankind US Stock ETF 0.01726 18.81 1.99919
ProShares Hedge Replication ETF 0.01655 5.92 1.47892
Vanguard ESG U.S. Stock ETF 0.01 23.74 1.26927
SPDR Portfolio MSCI Global Stock Market ETF 0.00758 15.66 2.19607
Avantis Responsible U.S. Equity ETF 0.00593 26.78 1.45257
Schwab U.S. Broad Market ETF 0.005 23.7 1.43354
iShares Russell 3000 ETF 0.00492 23.61 1.43482
Avantis U.S. Equity ETF 0.00371 20.45 1.59151
FlexShares Morningstar US Market Factor Tilt Index Fund 0.0034 20.03 1.69572
Vanguard Russell 3000 ETF 0 31.87 1.43817



Veileder Stillingstittel Betaling Fødselsår
Mr. Mark Elliott Boulding Executive VP & Chief Legal Officer 824.09k 1961 (64 år)
Mr. Eric Pauwels Chief Business Officer 847.67k 1961 (64 år)
Ms. Christine Utter Senior VP, Chief Accounting Officer & Head of People Services 595.54k 1978 (47 år)
Dr. Allan Steven Jacobson Ph.D. Co-Founder, Chairman of Scientific Advisory Board & Independent Director 145k 1946 (79 år)
Dr. Neil Almstead Ph.D. Chief Technical Operations Officer 829.97k 1967 (58 år)
Dr. Stuart W. Peltz Ph.D. Co-Founder, Senior Consultant & Member of Scientific Advisory Board 1.54M 1960 (65 år)
Alex Kane Investor Relations Officer N/A
Dr. Matthew B. Klein F.A.C.S., M.D., M.S. CEO & Director 995.4k 1972 (53 år)
Mr. Pierre Gravier M.S. Chief Financial Officer N/A 1986 (39 år)
Dr. Lee Golden M.D., Ph.D. Executive VP & Chief Medical Officer 1968 (57 år)

Adresse: United States, South Plainfield, NJ , 100 Corporate Court - åpne i Google maps, åpne Yandex-kart
Nettsted: http://www.ptcbio.com